Paperpal Prime Logo

Progres en Urologie : Impact Factor & More

eISSN: 2405-5131pISSN: 1166-7087

Key Metrics

CiteScore
1.3
Impact Factor
< 5
SNIP
0.4
Recommended pre-submission checks
Powered by Paperpal by Editage

Progres en Urologie Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher ELSEVIER MASSON, CORPORATION OFFICE
Language French
Frequency Monthly
General Details
LanguageFrench
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Progres en Urologie ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Progres en Urologie

Risk stratification in non-muscle-invasive bladder cancer in the era of expanding therapeutic options: Are current classifications still adequate?
  • 1 Dec 2026
  • The French journal of urology
Primary management and survival of non-metastatic prostate cancer in subjects aged 75years old and over. Analysis of data from a French cancer registry.
  • 1 Dec 2026
  • The French journal of urology
Discovery of potential new drug targets for cystitis and chronic cystitis: a drug target Mendelian randomization study.
  • 1 Dec 2026
  • The French journal of urology
Current practices in the management of stone-related renal colic during pregnancy in France: A national online survey from the CLAFU.
  • 1 Dec 2026
  • The French journal of urology
Beyond the trial: Can audit and feedback produce lasting improvements in transurethral resection of bladder tumor quality? Commentary on: Orecchia L, Gerardi M, Colalillo G, et al. Impact of audit and feedback on transurethral resection of bladder tumor quality: a monocentric post-completion evaluation of the RESECT trial. BJU Int. 2026;138:92-99.
  • 1 Dec 2026
  • The French journal of urology
Early versus delayed catheter removal after bipolar TURP: A prospective randomized study with long-term functional follow-up.
  • 1 Dec 2026
  • The French journal of urology
Risk stratification in non-muscle-invasive bladder cancer in the era of expanding therapeutic options: Are current classifications still adequate?
  • 1 Dec 2026
  • The French journal of urology
Primary management and survival of non-metastatic prostate cancer in subjects aged 75years old and over. Analysis of data from a French cancer registry.
  • 1 Dec 2026
  • The French journal of urology
Discovery of potential new drug targets for cystitis and chronic cystitis: a drug target Mendelian randomization study.
  • 1 Dec 2026
  • The French journal of urology
Current practices in the management of stone-related renal colic during pregnancy in France: A national online survey from the CLAFU.
  • 1 Dec 2026
  • The French journal of urology
Beyond the trial: Can audit and feedback produce lasting improvements in transurethral resection of bladder tumor quality? Commentary on: Orecchia L, Gerardi M, Colalillo G, et al. Impact of audit and feedback on transurethral resection of bladder tumor quality: a monocentric post-completion evaluation of the RESECT trial. BJU Int. 2026;138:92-99.
  • 1 Dec 2026
  • The French journal of urology
Early versus delayed catheter removal after bipolar TURP: A prospective randomized study with long-term functional follow-up.
  • 1 Dec 2026
  • The French journal of urology

FAQs on Progres en Urologie